In fact, neurons of the lamina terminalis a key brain structure for sensing thirst and regulating water balance (20, 21) express GLP-1 receptors and are believed to confer satiety of thirst during fluid ingestion (22)
The key regulatory milestones: FDA Breakthrough Therapy designation for MASH (September 2024) EMA PRIME designation for MASH (November 2023) China NMPA Breakthrough designation (June 2024) Phase 3 trials (SYNCHRONIZE-1 and SYNCHRONIZE-2) fully enrolled, results expected H1 of this year Estimated FDA filing: Late this year at the earliest Estimated FDA approval: Possibly next year, depending on Phase 3 results If Phase 3 results confirm Phase 2 findings, survodutide could reach the market within the next 12-24 months
They act as messengers, telling your organs, cells, and systems what to do and when to do it
While SURPASS-4 was not powered to evaluate differences in MACE-4 incidence between tirzepatide treatment groups and glargine, it was designed to fulfill the MACE-4 non-inferiority analysis requested by regulatory authorities to evaluate the cardiovascular safety of new glucose lowering medications
Factor 2: Your lowest dose must be measurable on your syringe
Eat Slowly & Mindfully : Mindful eating, chewing food thoroughly, and taking time during meals can help improve digestion and minimize post-meal discomfort